Analytic Investors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.87M Sell
72,573
-1,048
-1% -$39.4K 0.03% 239
2016
Q2
$2.61M Sell
73,621
-44,135
-37% -$1.72M 0.03% 245
2016
Q1
$4.61M Sell
117,756
-20,781
-15% -$777K 0.06% 207
2015
Q4
$5.95M Sell
138,537
-18,554
-12% -$816K 0.07% 193
2015
Q3
$6.6M Buy
157,091
+79,359
+102% +$3.71M 0.09% 178
2015
Q2
$3.88M Hold
77,732
0.05% 197
2015
Q1
$3.5M Buy
77,732
+73,047
+1,559% +$3.28M 0.05% 199
2014
Q4
$226K Buy
+4,685
New +$223K ﹤0.01% 496

Other funds holding MET

Analytic Investors's MET Position: Q3 2016 in Review

Analytic Investors reduced its MetLife (MET) stake by 1.4% in Q3 2016, selling an estimated $39.4K and leaving 72,573 shares worth $2.87M. The position accounts for 0.03% of the portfolio, ranked #239.

Analytic Investors first reported a position in MET in Q4 2014 and has held it in 8 quarters since. The position peaked at $6.6M in Q3 2015. 962 funds tracked by Wall St. Rank hold MET as of Q3 2016.

  • Analytic Investors held 72,573 shares of MetLife worth $2.87M as of Q3 2016.
  • Analytic Investors sold 1,048 MetLife shares in Q3 2016, an estimated $39.4K.
  • MetLife made up 0.03% of Analytic Investors's portfolio in Q3 2016, its #239 holding.
  • Analytic Investors first reported a position in MetLife in Q4 2014 and has held it in 8 quarters since.
  • Analytic Investors's MetLife position peaked at $6.6M in Q3 2015.
  • 962 funds tracked by Wall St. Rank held MetLife as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.